XML 65 R7.htm IDEA: XBRL DOCUMENT v3.22.4
Consolidated Statements of Changes in Equity and Redeemable Non-Controlling Interest - USD ($)
shares in Thousands, $ in Millions
Total
Cumulative Effect, Period of Adoption, Adjustment
Common Stock
Treasury Stock
Additional Paid-in Capital
Retained Earnings
Retained Earnings
Cumulative Effect, Period of Adoption, Adjustment
Accumulated Other Comprehensive Income/(Loss)
Non- Controlling Interest in Consolidated Subsidiaries
Accounting standards update extensible enumeration Accounting Standards Update 2016-13 [Member]                
Common stock, shares beginning (in shares) at Dec. 31, 2019     607,000            
Treasury stock, shares beginning (in shares) at Dec. 31, 2019       (53,000)          
Beginning balance at Dec. 31, 2019 $ 17,286 $ (10) $ 6 $ (3,879) $ 11,742 $ 9,629 $ (10) $ (243) $ 31
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Other comprehensive income 51             51  
Stock consideration issued for acquisition (in shares)     18,000            
Stock consideration issued for acquisition $ 1,895       1,895        
Exercise of common stock options (in shares) 723   1,000            
Exercise of common stock options $ 31       31        
Repurchases of common stock (in shares) (13,603)     (14,000)          
Repurchases of common stock $ (1,247)     $ (1,247)          
Payments relating to treasury shares (in shares) (1,000)     (1,000)          
Payments relating to treasury shares $ (74)     $ (74)          
Stock-based compensation 141       141        
Issuance under the employee stock purchase plan 33       33        
Warrants issued to minority interest holders 3       3        
Issuance of restricted stock (in shares)     2,000            
Distributions of profits (31)               (31)
Dividends paid to stockholders (669)         (669)      
Issuance of non-controlling interest 9               9
Net income/(loss) attributable to non-controlling interest 8         (19)     27
Net income 2,108         2,108      
Common stock, shares ending (in shares) at Dec. 31, 2020     629,000            
Treasury stock, shares ending (in shares) at Dec. 31, 2020       (68,000)          
Ending balance at Dec. 31, 2020 19,534   $ 6 $ (5,200) 13,845 11,039   (192) 36
Redeemable non-controlling interest, Beginning balance at Dec. 31, 2019 78                
Increase (Decrease) in Temporary Equity [Roll Forward]                  
Repurchases of common stock 11                
Warrants issued to minority interest holders 2                
Redeemable non-controlling interest (10)                
Net income attributable to non-controlling interest (8)                
Redeemable non-controlling interest, Ending balance at Dec. 31, 2020 93                
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Other comprehensive income $ (4)             (4)  
Exercise of common stock options (in shares) 493                
Exercise of common stock options $ 17       17        
Repurchases of common stock (in shares) (1,834)     (1,000)          
Repurchases of common stock $ (250)     $ (250)          
Payments relating to treasury shares (in shares) (1,000)     (1,000)          
Payments relating to treasury shares $ (70)     $ (70)          
Stock-based compensation 168       168        
Issuance under the employee stock purchase plan 42       42        
Issuance of restricted stock (in shares)     2,000            
Distributions of profits (21)               (21)
Dividends paid to stockholders (747)         (747)      
Bakkt deconsolidation adjustment (3)       (3)        
Net income/(loss) attributable to non-controlling interest 13         (11)     24
Net income $ 4,069         4,069      
Common stock, shares ending (in shares) at Dec. 31, 2021 561,000   631,000            
Treasury stock, shares ending (in shares) at Dec. 31, 2021       (70,000)          
Ending balance at Dec. 31, 2021 $ 22,748   $ 6 $ (5,520) 14,069 14,350   (196) 39
Increase (Decrease) in Temporary Equity [Roll Forward]                  
Repurchases of common stock 27                
Bakkt deconsolidation adjustment (107)                
Net income attributable to non-controlling interest (13)                
Redeemable non-controlling interest, Ending balance at Dec. 31, 2021 0                
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Other comprehensive income $ (135)             (135)  
Exercise of common stock options (in shares) 417                
Exercise of common stock options $ 22       22        
Repurchases of common stock (in shares) (4,955)     (4,000)          
Repurchases of common stock $ (632)     $ (632)          
Payments relating to treasury shares (in shares) (1,000)     (1,000)          
Payments relating to treasury shares $ (73)     $ (73)          
Stock-based compensation 172       172        
Issuance under the employee stock purchase plan (in shares)     1,000            
Issuance under the employee stock purchase plan 50       50        
Issuance of restricted stock (in shares)     2,000            
Distributions of profits (36)               (36)
Dividends paid to stockholders (853)         (853)      
Net income/(loss) attributable to non-controlling interest 0         (52)     52
Net income $ 1,498                
Common stock, shares ending (in shares) at Dec. 31, 2022 559,000   634,000            
Treasury stock, shares ending (in shares) at Dec. 31, 2022       (75,000)          
Ending balance at Dec. 31, 2022 $ 22,761   $ 6 $ (6,225) $ 14,313 $ 14,943   $ (331) $ 55
Increase (Decrease) in Temporary Equity [Roll Forward]                  
Repurchases of common stock 0                
Net income attributable to non-controlling interest 0                
Redeemable non-controlling interest, Ending balance at Dec. 31, 2022 $ 0